USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Spraying pesticides for a living increases the risk of erectile dysfunction. Our denial of this fact may mask a deeper fear: ...

GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with lasting benefits and manageable side effects.

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with ...

The primary purpose was to evaluate the long term effects of tirzepatide on body weight and on the risk of developing type 2 diabetes.

A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight ...

Consuming grape juice 5 times or more per week was associated with 79% reduced odds of erectile dysfunction compared with no consumption.

The new research summarized vision problems of nine people with type 2 diabetes taking either semaglutide or tirzepatide, which are GLP-1 medicines. Semaglutide is known by the brand names Ozempic ...

Treatment with tirzepatide tie to reduction in heart failure risk outcomes in patients with heart failure with preserved ejection fraction.

Drug manufacturer Eli Lilly announced the results from a three-year study that found its drug tirzepatide slashed the risk of developing type 2 diabetes by 94% in adults with prediabetes who also ...